Skip to content

12 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

Concomitant hypertension in hypertrophic cardiomyopathy: cardiovascular magnetic resonance biomarkers to guide cardiovascular prevention

Although hypertension is present in 25–50% of patients with hypertrophic cardiomyopathy (HCM), its clinical characterization and prognostic implications in this population remain insufficiently investigated.(1) To describe the phenotype of hypertensive patients with HCM using cardiovascular magnetic resona...

J. Florence, T. Goncalves, S. Toupin et al. · 0 citations
Open access Oct 2026

A Visual LGE Extent Cutoff for Mortality Risk Stratification in Ischemic Cardiomyopathy.

BACKGROUND Late gadolinium enhancement (LGE) extent has been linked to adverse outcomes in ischemic cardiomyopathy (ICM). While quantitative methods of LGE assessment are widely accepted, semi-quantitative methods remain debated but still hold value. This study aimed to determine an optimal LGE segments cutoff for ICM...

Alexandre Unger, J. Garot, S. Duhamel et al. · 0 citations
Open access Oct 2026

Sex-related differences of late gadolinium enhancement granularity in hypertrophic cardiomyopathy: a cardiovascular magnetic resonance study

Although prognosis in hypertrophic cardiomyopathy (HCM) differs between women and men, sex-related differences regarding cardiovascular magnetic resonance (CMR) features, especially late gadolinium enhancement (LGE), remains poorly studied. To assess the sex-related prognostic value of the “LGE granularity...

F. Abadie, J. Florence, Y. Bohbot et al. · 0 citations
Oct 2026

Prognostic impact of late gadolinium enhancement granularity using cardiovascular magnetic resonance in end-stage hypertrophic cardiomyopathy

In this large multicenter cohort of end-stage HCM patients, the LGE granularity model integrating the LGE extent, location, and pattern provided strong and independent prognostic value beyond traditional prognostic factors.

J. Hudelo, J. Garot, S. Toupin et al. · 0 citations
Open access Oct 2026

Prognostic Value of Late Gadolinium Enhancement Findings in Isolated Left Ventricular Dilatation and Dilated Cardiomyopathy.

LGE findings were strongly and independently associated with death in both ILVD and DCM patients, with each successive LGE characteristic providing significant incremental prognostic value beyond traditional prognosticators, including LVEF.

Trecy Gonçalves, S. Duhamel, Solenn Toupin et al. · 0 citations
Open access Oct 2026

Clinical implications of late gadolinium enhancement in patients with active cancer undergoing stress CMR

Cardiovascular disease and cancer are the two leading causes of mortality worldwide. (1) Advances in oncologic therapies have improved cancer survival, resulting in a growing population of patients with active malignancy or cancer survivors who remain at increased risk of cardiovascular and non-cancer mortality....

A. Afana, S. Duhamel, S. Toupin et al. · 0 citations
Review Open access Sep 2026

Catheter-Based Renal Denervation in Uncontrolled and Resistant Hypertension: Evidence, Guidelines, Special Populations and Clinical Implementation

Hypertension remains the leading modifiable cause of cardiovascular death, yet fewer than one in four treated adults achieves guideline-recommended blood pressure targets. Catheter-based renal denervation interrupts efferent and afferent renal sympathetic signalling and lowers blood pressure continuously and independen...

Ioannis Skalidis, L. Koliastasis, P. Vlachakis et al. · 0 citations
Open access Oct 2026

Percutaneous coronary intervention using sirolimus-eluting balloons in patients at high bleeding risk: the SELUTION DeNovo HBR substudy.

BACKGROUND Drug-eluting stents (DES) are the current mainstay of percutaneous coronary intervention (PCI) in high bleeding risk (HBR) patients. However, drug-coated balloons may be an alternative that reduces reliance on prolonged courses of antiplatelet therapy. AIMS The SELUTION DeNovo trial randomised 3,323 PCI ca...

Tuomas T. Rissanen, Simon Eccleshall, Florian Krackhardt et al. · 0 citations
Open access Sep 2026

Multimodality imaging for pre-, intra-, and postprocedural guidance of left atrial appendage closure: a European Left Atrial Appendage Closure Club (ELAACC) expert consensus statement.

Left atrial appendage closure (LAAC) is an established alternative for stroke prevention in patients with non-valvular atrial fibrillation who are not suitable candidates for long-term oral anticoagulation. Imaging is central to procedural success and safety, yet variability in acquisition, measurement, and reporting c...

Nina C. Wunderlich, Laura Sanchis Ruiz, Adel Aminian et al. · 0 citations
Open access Sep 2026

Vasodilator stress perfusion CMR for outcome prediction in patients under 45 years with suspected CAD.

BACKGROUND Although the prognostic value of vasodilator stress cardiovascular magnetic resonance (CMR) is established, it has never been assessed in patients <45 years with suspected coronary artery disease. The aim was to assess the long-term prognostic value of stress CMR to predict mortality in a multicenter cohort...

Elsa Richard de Vesvrotte, J. Garot, S. Duhamel et al. · 0 citations
Review Aug 2026

Large language models in interventional cardiology: current evidence and future directions.

LLMs are unlikely to replace interventional cardiologists in the foreseeable future, but they may meaningfully support decision-making, education, and patient communication in a domain where speed, complexity, and risk converge.

Ioannis Skalidis, Lisa Simioni, G. Beretta et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.